1型糖尿病青少年女孩在临床神经病变证据出现前即发生骨改变
单中心横断面研究比较21例1型糖尿病青少年女孩与12例匹配对照,发现1型糖尿病组桡骨和胫骨小梁骨体积分数及厚度降低、胫骨皮质骨密度升高而孔隙率降低,骨钙素和I型胶原交联C端肽降低;仅9.5%有临床周围神经病变证据,神经病变状态未能解释骨改变。
要点
- 1型糖尿病青少年女孩在无临床神经病变时已出现小梁骨微结构缺损。
- 胫骨皮质骨密度升高8.6%、孔隙率降低52.9%,仅见于胫骨。
- 骨钙素降低30%、I型胶原交联C端肽降低36%,提示骨形成与转换低下。
核心结论
- 研究定义了1型糖尿病青少年女孩在症状性周围神经病变出现前即存在小梁骨微结构早期缺损、胫骨皮质孔隙率降低及骨转换生物标志物抑制。
研究设计与样本
- 单中心横断面研究,纳入1型糖尿病青少年女孩21例和相关对照12例,两组在年龄、身高、力量和体力活动方面匹配良好。
主要发现
- 高分辨率外周定量CT显示,校正体型后1型糖尿病组桡骨远端小梁骨体积分数降低14.6%(P-adj=.095),胫骨降低12.8%(P-adj=.017)。
- 1型糖尿病组桡骨小梁厚度降低8.3%(P-adj=.007),胫骨降低7.5%(P-adj=.034)。
- 仅在胫骨,1型糖尿病组皮质骨密度升高8.6%(P-adj=.024),孔隙率降低52.9%(P-adj=.012)。
- 双能X线吸收法测定的骨密度无显著差异;1型糖尿病组骨钙素降低30%(P=.057),I型胶原交联C端肽降低36%(P=.035)。
- 根据密歇根神经病变筛查量表,9.5%的1型糖尿病参与者有糖尿病周围神经病变的临床证据,但神经病变状态未能解释1型糖尿病相关的广泛骨改变。
临床怎么用
- 作者认为,这些发现有助于理解1型糖尿病年轻女孩骨骼疾病的快速进展,并提示早期发现和管理策略可能有助于预防日后骨折及相关共病。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Neuropathy and fracture are prevalent complications of type 1 diabetes (T1D). Although correlated in the clinical literature, it remains unknown whether neuropathy contributes to the initiation of bone loss at the earliest stages of disease. METHODS: We performed a single-center, cross-sectional study to quantify parameters of nerve and bone health in adolescent girls with T1D (n = 21) and associated controls (n = 12). Groups were well matched for age, height, strength, and physical activity. RESULTS: By high-resolution peripheral quantitative computed tomograpy, participants with T1D had lower trabecular bone volume fraction at the distal radius (-14.6%, P-adj = .095) and the tibia (-12.8%, P-adj = .017) and decreased trabecular thickness (-8.3% radius, P-adj = .007; -7.5% tibia, P-adj = .034) after adjustment for body size. In the tibia only, cortical bone mineral density was increased by 8.6% (P-adj = .024) and porosity was decreased by 52.9% with T1D (P-adj = .012). There were no significant differences in bone density by dual-energy x-ray absorptiometry. Participants with T1D also had lower circulating levels of osteocalcin (-30%, P = .057), and type I collagen cross-linked C-telopeptide (-36%, P = .035), suggesting low bone formation and turnover in T1D. Based on the Michigan Neuropathy Screening Instrument, 9.5% of those with T1D had clinical evidence of diabetic peripheral neuropathy. However, consideration of neuropathy status failed to explain the widespread T1D-associated changes in bone. CONCLUSION: Our study defines early deficits in trabecular bone microarchitecture, decreased cortical porosity in the tibia, and suppression of biomarkers of bone turnover in adolescent girls with T1D, prior to the onset of symptomatic peripheral neuropathy. These findings inform our understanding of the rapid progression of skeletal disease in young girls with T1D and suggests that early detection and management strategies may help to prevent fracture and related comorbidities later in life.
引用
- Shen I, Usala RL, Mohseni M, et al. Adolescent Girls With Type 1 Diabetes Develop Changes in Bone Prior to Evidence of Clinical Neuropathy. J Clin Endocrinol Metab. 2025. PMID: 39056255. doi:10.1210/clinem/dgae511
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。